Results 151 to 160 of about 58,549 (319)

The molecular defect in type IIB von Willebrand disease. Identification of four potential missense mutations within the putative GpIb binding domain. [PDF]

, 1991
Kathleen A. Cooney, William C. Nichols, M E Bruck, Wadie F. Bahou, Amy D. Shapiro, Ejw Bowie, H R Gralnick, David Ginsburg   +7 more
openalex   +1 more source

How Trustworthy is Light Transmittance Platelet Aggregometry With Low Platelet Count Samples? Insights From Test Replicates and Retrospective Analysis of Several Decades of Diagnostic Samples

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction Light transmission platelet aggregometry (LTA) is useful to diagnose platelet function disorders (PFD). We evaluated the precision and reproducibility of LTA with low platelet count platelet‐rich plasma (LPRP). Methods LPRP maximal aggregation (MA) precision for informative agonists and LTA reproducibility were assessed using ...
Catherine P. M. Hayward, Rabab Al Dawood, Lindsay Wice, Karen A. Moffat   +3 more
wiley   +1 more source

Purified human factor VIII procoagulant protein: comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs.

, 1985
K. M. Brinkhous, H. Sandberg, J. B. Garris, C. Mattsson, M. Palm, T. Griggs, M. S. Read   +6 more
openalex   +2 more sources

Characterization of Leu777Pro and Ile865Thr type IIA von Willebrand disease mutations [PDF]

, 1994
SE Lyons, Kathleen A. Cooney, PL Bockenstedt, David Ginsburg   +3 more
openalex   +1 more source

Determination of Fibrinogen Ratio Cutoff Limits Using Indirect Reference Interval Methodology

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction Discordant fibrinogen antigen to activity ratios are utilized by clinicians as evidence of dysfibrinogenemia. Abnormal ratio cutoffs implemented by clinical laboratories are typically determined by validation studies that include limited numbers of samples.
Abdulrahman Saadalla, Kelly Doyle, Karen Moser, Kristi Smock   +3 more
wiley   +1 more source

Influence of mutations and size of multimers in type II von Willebrand disease upon the function of von Willebrand factor [PDF]

, 1994
Olivier D. Christophe, Anne‐Sophie Ribba, Dominique Baruch, Bernadette Obert, Christine Rouault, K. Niinomi, Geneviève Piétu, Dominique Meyer, JP Girma   +8 more
openalex   +1 more source

Von Willebrand disease [PDF]

Clinical Medicine, 2007
openaire   +3 more sources

Common Hematologic Emergencies—Acute Promyelocytic Leukemia and Microangiopathic Hemolytic Anemias—A Pivotal Role of Clinical Laboratory

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Hematologic emergencies are urgent health conditions which result in significant mortality and morbidity unless timely therapeutic measures are taken. Therapeutic success depends on their timely and accurate recognition by hematology laboratory services.
Ganna Shestakova, Nicolas Ulrich Edgar, Anton V. Rets   +2 more
wiley   +1 more source

von Willebrand factor and von Willebrand disease [published erratum appears in Blood 1988 Mar;71(3):830]

, 1987
ZM Ruggeri, TS Zimmerman
openalex   +1 more source

Identification of three candidate mutations causing type IIA von Willebrand disease using a rapid, nonradioactive, allele-specific hybridization method [PDF]

, 1993
Aida Inbal, T Englender, Nurit Kornbrot, AM Randi, Giancarlo Castaman, PM Mannucci, J. Evan Sadler   +6 more
openalex   +1 more source